Ajinomoto Bio-Pharma Services, a provider of biopharmaceutical contract development and manufacturing services, has developed a new enzyme for double strand oligonucleotide formation with high productivity.   In collaboration with researchers from the University of Shizuoka, Aji Bio-Pharma developed a highly functional artificial RNA ligase using the ancestral design method. It was found that this artificial RNA ligase has higher thermostability than natural RNA ligase as well as superior liga...